TC
WST icon

TradeLink Capital’s West Pharmaceutical WST Stock Holding History

TradeLink Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,000
Closed -$425K – 25
2019
Q3 		$425K Buy
+3,000
New +$413K 2.98% 9
2014
Q1 		– Sell
-7,300
Closed -$358K – 294
2013
Q4 		$358K Buy
+7,300
New +$342K 0.48% 41

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

TradeLink Capital's WST Position: Q4 2019 in Review

TradeLink Capital sold out of West Pharmaceutical (WST) in Q4 2019, closing a stake of 3,000 shares — an estimated $425K sold.

TradeLink Capital first reported a position in WST in Q4 2013 and held it in 2 quarters. The position peaked at $425K in Q3 2019. 445 funds tracked by Wall St. Rank hold WST as of Q4 2019.

  • TradeLink Capital reported no remaining West Pharmaceutical position as of Q4 2019 after selling out during the quarter.
  • TradeLink Capital sold 3,000 West Pharmaceutical shares in Q4 2019, an estimated $425K.
  • TradeLink Capital first reported a position in West Pharmaceutical in Q4 2013 and held it in 2 quarters.
  • TradeLink Capital's West Pharmaceutical position peaked at $425K in Q3 2019.
  • 445 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2019.

Based on TradeLink Capital's 13F filing for Q4 2019, filed 10 Feb 2020.